Regulatory Considerations for Physiological Closed-Loop Controlled Medical Devices Used for Automated Critical Care: Food and Drug Administration Workshop Discussion Topics.
PMID: 28763355 · 2018
B, a, h, r, a, m, , P, a, r, v, i, n, i, a, n, ;, , C, h, r, i, s, t, o, p, h, e, r, , S, c, u, l, l, y, ;, , H, a, n, n, i, e, b, e, y, , W, i, y, o, r, ;, , A, l, l, i, s, o, n, , K, u, m, a, r, ;, , S, a, n, d, y, , W, e, i, n, i, n, g, e, r
광고
초록
Part of the mission of the Center for Devices and Radiological Health (CDRH) at the US Food and Drug Administration is to facilitate medical device innovation. Therefore, CDRH plays an important role in helping its stakeholders such as manufacturers, health care professionals, patients, patient advocates, academia, and other government agencies navigate the regulatory landscape for medical devices. This is particularly important for innovative physiological closed-loop controlled (PCLC) devices
광고
공식 출처
PubMed에서 보기 →데이터는 PubMed / NCBI에서 제공됩니다. 전문과 최신 정보는 반드시 공식 기록을 확인하세요.